Reduced expression of programmed cell death protein 1 on peripheral regulatory B cells in pre-eclampsia – Signs of impaired immune suppression

Authors: Salby, Sophie Brondt ^{a, b, c}, Persson, Gry ^{a, b, c}, Pedersen, Nanna Heldager ^{a, b, c}, Turan, Gökmen ^{a, b, c}, Kimmerslev, Laura ^{a, b, c}, Finne, Katrine Folmann ^{a, b, c, d}, Weisdorf, Iben ^{a, b, c}, Lebech, Morten ^{c, e}, Hviid, Thomas Vauvert F. ^{a, b, c, 1, ⁎}

Source: In Journal of Reproductive Immunology March 2025 168

Opposing impacts of HLA-G haplotypes PROMO-G010104-UTR-3 and PROMO-G010101b/c-UTR-4 on risk of recurrent implantation failure

Authors: Papúchová, Henrieta, Saxtorph, Malene Hviid, Hallager, Trine, Jepsen, Ida E., Eriksen, Jens O., Persson, Gry, Funck, Tina, Weisdorf, Iben, Macklon, Nicholas, Larsen, Lise Grupe, Hviid, Thomas Vauvert F.

Source: In Reproductive BioMedicine Online September 2023 47(3)

Endometrial HLA-F expression is influenced by genotypes and correlates differently with immune cell infiltration in IVF and recurrent implantation failure patients

Authors: Papúchová, Henrieta, Saxtorph, Malene Hviid, Hallager, Trine, Jepsen, Ida E, Eriksen, Jens O, Persson, Gry, Funck, Tina, Weisdorf, Iben, Macklon, Nicholas S, Larsen, Lise Grupe, Hviid, Thomas Vauvert F

Source: Human reproduction. 37(8):1816-1834

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100157068187.0x000001&indx=1&recIds=ETOCvdc_100157068187.0x000001

Characterization of HLA-G Regulation and HLA Expression in Breast Cancer and Malignant Melanoma Cell Lines upon IFN-γ Stimulation and Inhibition of DNA Methylation.

Authors: Jørgensen, Nanna, Sayed, Abid, Jeppesen, Helene Bjerregaard, Persson, Gry, Weisdorf, Iben, Funck, Tina, Hviid, Thomas Vauvert Faurschou

Source: International Journal of Molecular Sciences; Jun2020, Vol. 21 Issue 12, p4307, 1p

Subject Terms: MELANOMA, DNA methylation, CELL lines, BREAST cancer, HLA histocompatibility antigens, INTERFERONS, HISTOCOMPATIBILITY class I antigens, INTERFERON receptors